Clinical Trial

Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 1, 2024 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the efficacy and safety of VA combined with HAAG in the induction treatment of newly diagnosed acute myeloid leukemia.
Trial Details
NCT Number NCT06394011
Lead Sponsor The First Affiliated Hospital of Soochow University
Conditions Intermediate Risk Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia
Enrollment 60 participants
Start Date 2024-02-15
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-05-01